• Needham & Company LLC Reaffirms "Buy" Rating for NewAmsterdam Pharma (NASDAQ:NAMS)

    المصدر: Buzz FX / 07 نوفمبر 2024 08:26:16   America/Chicago


    Needham & Company LLC Reaffirms "Buy" Rating for NewAmsterdam Pharma (NASDAQ:NAMS) Written by MarketBeat November 7, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) 's stock had its "buy" rating re
    Read more...
شارك على،